Skip to main content
Livermore
Livermore
ZHEN

Cumberland Pharmaceuticals Inc

CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001087294

No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.

Holders of 5% or more of CPIX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Cumberland Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CPIX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Kazimi A J13G40.80%5.70M sharesNewFeb 13, 20251 filingFeb 13, 2025SEC
Integrated Core Strategies (US) LLC13G/A5.80%809.9K shares−3.00 ppfrom 8.80%Feb 11, 20252 filingsApr 24, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Cumberland Pharmaceuticals Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CPIX
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20255:26 PM ETIkarian Capital, LLCand 1 other13G4.90%730.9K sharesNewBelow 5%Mar 31, 2025SEC
Apr 24, 20254:02 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A5.80%809.9K shares−3.00 ppfrom 8.80%Mar 31, 2025SEC
Feb 13, 20255:26 PM ETKazimi A J13G40.80%5.70M sharesNewFeb 13, 2025SEC
Feb 11, 20254:00 PM ETIntegrated Core Strategies (US) LLCand 3 others13G8.80%1.23M sharesNewFeb 5, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Cumberland Pharmaceuticals Inc shares.

No Form 144 notices for Cumberland Pharmaceuticals Inc are on file.